Pentoxifylline
Pentoxifylline is listed in the FDA National Drug Code directory with 9 NDC codes, marketed under brand names including Pentoxifylline, TRENTAL. Available dosage forms: tablet, extended release, powder, tablet.
Drug details
- Generic Name
- Pentoxifylline
- Brand Names
- Pentoxifylline, TRENTAL
- Application Number
- ANDA074425
- Sponsor
- Rising Pharma Holdings, Inc.
- NDC Codes
- 9
- Dosage Forms
- TABLET, EXTENDED RELEASE, POWDER, TABLET
- Routes
- ORAL
- Active Ingredients
- PENTOXIFYLLINE
Indications and Usage
INDICATIONS & USAGE Pentoxifylline extended-release tablets are indicated for the treatment of patients with intermittent claudication on the basis of chronic occlusive arterial disease of the limbs. Pentoxifylline extended-release tablets can improve function and symptoms but is not intended to replace more definitive therapy, such as surgical bypass, or removal of arterial obstructions when treating peripheral vascular disease.